149 related articles for article (PubMed ID: 35872844)
1. Exendin-4 Attenuates Hepatic Steatosis by Promoting the Autophagy-Lysosomal Pathway.
Yu HH; Wang HC; Hsieh MC; Lee MC; Su BC; Shan YS
Biomed Res Int; 2022; 2022():4246086. PubMed ID: 35872844
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway.
Fang Y; Ji L; Zhu C; Xiao Y; Zhang J; Lu J; Yin J; Wei L
Front Cell Dev Biol; 2020; 8():602574. PubMed ID: 33330497
[TBL] [Abstract][Full Text] [Related]
3. [Exendin-4 promotes autophagy to relieve lipid deposition in a NAFLD cell model by activating AKT/mTOR signaling pathway].
Lin C; Fang J; Xiang Q; Zhou R; Yang L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1073-1078. PubMed ID: 34308859
[TBL] [Abstract][Full Text] [Related]
4. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-Like Peptide 1 Protects Pancreatic β-Cells From Death by Increasing Autophagic Flux and Restoring Lysosomal Function.
Zummo FP; Cullen KS; Honkanen-Scott M; Shaw JAM; Lovat PE; Arden C
Diabetes; 2017 May; 66(5):1272-1285. PubMed ID: 28232493
[TBL] [Abstract][Full Text] [Related]
6. ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis.
Fucho R; Martínez L; Baulies A; Torres S; Tarrats N; Fernandez A; Ribas V; Astudillo AM; Balsinde J; Garcia-Rovés P; Elena M; Bergheim I; Lotersztajn S; Trautwein C; Appelqvist H; Paton AW; Paton JC; Czaja MJ; Kaplowitz N; Fernandez-Checa JC; García-Ruiz C
J Hepatol; 2014 Nov; 61(5):1126-34. PubMed ID: 24946279
[TBL] [Abstract][Full Text] [Related]
7. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
[TBL] [Abstract][Full Text] [Related]
8. Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease.
Ding H; Ge G; Tseng Y; Ma Y; Zhang J; Liu J
Ann Hepatol; 2020; 19(5):516-522. PubMed ID: 32553647
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4.
Errafii K; Al-Akl NS; Khalifa O; Arredouani A
J Transl Med; 2021 Jun; 19(1):235. PubMed ID: 34078383
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca
Zummo FP; Krishnanda SI; Georgiou M; O'Harte FP; Parthsarathy V; Cullen KS; Honkanen-Scott M; Shaw JA; Lovat PE; Arden C
Autophagy; 2022 Apr; 18(4):799-815. PubMed ID: 34338148
[TBL] [Abstract][Full Text] [Related]
11. Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery.
Pi H; Liu M; Xi Y; Chen M; Tian L; Xie J; Chen M; Wang Z; Yang M; Yu Z; Zhou Z; Gao F
FASEB J; 2019 Nov; 33(11):11870-11883. PubMed ID: 31366243
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
13. CREBH promotes autophagy to ameliorate NASH by regulating Coro1a.
Deng X; Liu B; Jiang Q; Li G; Li J; Xu K
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166914. PubMed ID: 37837948
[TBL] [Abstract][Full Text] [Related]
14. Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells.
Khalifa O; Ouararhni K; Errafii K; Alajez NM; Arredouani A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511368
[TBL] [Abstract][Full Text] [Related]
15. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
[TBL] [Abstract][Full Text] [Related]
16. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
17. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model.
Allam MM; El Gazzar WB
Arch Physiol Biochem; 2018 Feb; 124(1):10-17. PubMed ID: 28696785
[TBL] [Abstract][Full Text] [Related]
19. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
20. PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes.
Negoita F; Blomdahl J; Wasserstrom S; Winberg ME; Osmark P; Larsson S; Stenkula KG; Ekstedt M; Kechagias S; Holm C; Jones HA
J Cell Biochem; 2019 Jan; 120(1):343-356. PubMed ID: 30171718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]